Literature DB >> 1679841

Dual muscarinic and nicotinic action on a motor program in Drosophila.

M G Gorczyca1, V Budnik, K White, C F Wu.   

Abstract

The effect of cholinergic agonists and antagonists on the central pattern generator of the pharyngeal muscles has been studied in third instar larvae of Drosophila. The pharyngeal muscles are a group of rhythmically active fibers involved in feeding. Bath application of the cholinergic agonists carbachol, muscarine, pilocarpine, and acetylcholine (ACh) to a semiintact preparation including the pharyngeal muscles and the central nervous system (CNS), initiated long-lasting endogenous-like bursting activity in the muscles. The muscarinic antagonists, atropine and scopolamine, blocked these responses as well as endogenous activity. Perfusion with nicotine elicited a short, tonic response that was marginally blocked by mecamylamine but not by curare, alpha-bungarotoxin, hexamethonium, or the muscarinic antagonists. This is the first time that a response to cholinergic drugs has been examined in Drosophila. The pharyngeal muscle preparation may prove to be a valuable system for studying mutations of cholinergic metabolism, receptors, and second messengers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679841     DOI: 10.1002/neu.480220407

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  14 in total

1.  A role for muscarinic excitation: control of specific singing behavior by activation of the adenylate cyclase pathway in the brain of grasshoppers.

Authors:  R Heinrich; B Wenzel; N Elsner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  The shaking-B2 mutation disrupts electrical synapses in a flight circuit in adult Drosophila.

Authors:  J R Trimarchi; R K Murphey
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

3.  Release of a single neurotransmitter from an identified interneuron coherently affects motor output on multiple time scales.

Authors:  Andrew M Dacks; Klaudiusz R Weiss
Journal:  J Neurophysiol       Date:  2013-02-13       Impact factor: 2.714

4.  Temporal and spatial expression patterns of two G-protein coupled receptors in Drosophila melanogaster.

Authors:  F Hannan; L M Hall
Journal:  Invert Neurosci       Date:  1996-06

5.  Antennal motor activity induced by pilocarpine in the American cockroach.

Authors:  Jiro Okada; Yusuke Morimoto; Yoshihiro Toh
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2009-01-30       Impact factor: 1.836

6.  Tissue-specific targeting of Hsp26 has no effect on heat resistance of neural function in larval Drosophila.

Authors:  Viara Mileva-Seitz; Chengfeng Xiao; Laurent Seroude; R Meldrum Robertson
Journal:  Cell Stress Chaperones       Date:  2008-02-15       Impact factor: 3.667

7.  Characterization of buccal motor programs elicited by a cholinergic agonist applied to the cerebral ganglion of Aplysia californica.

Authors:  A J Susswein; S C Rosen; S Gapon; I Kupfermann
Journal:  J Comp Physiol A       Date:  1996-10       Impact factor: 1.836

8.  A specific synaptic pathway activates a conditional plateau potential underlying protraction phase in the Aplysia feeding central pattern generator.

Authors:  Nikolai C Dembrow; Jian Jing; Vladimir Brezina; Klaudiusz R Weiss
Journal:  J Neurosci       Date:  2004-06-02       Impact factor: 6.167

9.  Overexpression of the vesicular acetylcholine transporter disrupts cognitive performance and causes age-dependent locomotion decline in Drosophila.

Authors:  Shardae S Showell; Yessica Martinez; Sophia Gondolfo; Sridhar Boppana; Hakeem O Lawal
Journal:  Mol Cell Neurosci       Date:  2020-03-23       Impact factor: 4.314

10.  Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression.

Authors:  H O Lawal; A Terrell; H A Lam; C Djapri; J Jang; R Hadi; L Roberts; V Shahi; M-T Chou; T Biedermann; B Huang; G M Lawless; N T Maidment; D E Krantz
Journal:  Mol Psychiatry       Date:  2012-12-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.